Longeveron LGVN
NASDAQ LGVN
$3.30 +0.46 (+16.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Longeveron (LGVN) Return on Equity [ROE] (2021 - 2026)

Updated

Longeveron's Return on Equity [ROE] came in at -179.01% for Q2 2026, down 48.14 percentage points from -130.86% a year earlier but up 31.86 percentage points from the prior quarter.

Analysis

Longeveron (LGVN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Longeveron's Return on Equity [ROE] was -168.98%, down 53.55 percentage points from FY2024.

  • Return on Equity [ROE] carries a four-year change of -82.48 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -115.43% in FY2024 (+38.95 pp), -154.38% in FY2023 (-89.38 pp), -65.00% in FY2022 (+21.50 pp) and -86.50% in FY2021.
  • The five-year range for quarterly Return on Equity [ROE] is -415.52% (Q1 2024) to -48.62% (Q1 2022).
  • Year-over-year, Return on Equity [ROE] has declined for four consecutive quarters, with an average year-over-year change of +33.65 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 325.31 percentage points), and the weakest in Q1 2024 (a drop of 307.04 percentage points).
  • Business Quant data shows LGVN's Return on Equity [ROE] at -210.87% (Q1 2026), -297.77% (Q4 2025) and -196.00% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00 -179.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -179.01%
Mar 31, 2026 -210.87%
Dec 31, 2025 -297.77%
Sep 30, 2025 -196.00%
Jun 30, 2025 -130.86%
Mar 31, 2025 -90.21%
Dec 31, 2024 -69.54%
Sep 30, 2024 -87.23%
Jun 30, 2024 -202.69%
Mar 31, 2024 -415.52%
Dec 31, 2023 -312.27%
Sep 30, 2023 -222.37%
Jun 30, 2023 -144.88%
Mar 31, 2023 -108.48%
Dec 31, 2022 -83.49%
Sep 30, 2022 -68.33%
Jun 30, 2022 -56.71%
Mar 31, 2022 -48.62%
Mar 31, 2021 -672.17%
API Access

Longeveron Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LGVN&period=max&api_key=YOUR_API_KEY